HealthMore in Health→
Parkinson’s drug shows promise for resistant depression
Key Takeaways
- A nine-week trial tested pramipexole as an add-on therapy for treatment-resistant depression with marked anhedonia.
- Patients receiving pramipexole improved more than the placebo group.
- Brain imaging suggested effects on reward-related ventral striatal activity.
DE
DT Editorial Team··via medicalxpress.com